ust under a year ago, Veritas Genetics announced it would be launching the first whole genome sequencing test with a price tag under $1,000. Now, the company is bringing on board a new vice president of clinical affairs to help lower the cost of that sequencing and improve the process of interpreting the results.

Birgit Funke has worked extensively on the genetic underpinnings of inherited heart diseases, including cardiomyopathies, and has also written about the racial disparities in genetic testing and research. As of February 1, Funke has split her time between the Danvers, Mass.-based spinoff of the non-profit Personal Genome Project and her work as an associate professor at Harvard Medical School and a researcher at Partners Personalized Medicine’s Laboratory of Molecular Medicine.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.